Biogen Inc. (BIIB)
NASDAQ: BIIB · Real-Time Price · USD
179.96
-4.42 (-2.40%)
Apr 27, 2026, 2:44 PM EDT - Market open
Biogen Analyst Ratings
Total Analysts
26
Consensus Rating
Buy
Price Target
$203.16
Upside
+12.89%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Hold → Strong Buy Upgrades $185 → $225 | Hold → Strong Buy | Upgrades | $185 → $225 | +25.03% | Apr 22, 2026 |
| Wells Fargo | Wells Fargo | Hold → Buy Upgrades $200 → $250 | Hold → Buy | Upgrades | $200 → $250 | +38.92% | Apr 20, 2026 |
| Piper Sandler | Piper Sandler | Hold → Buy Upgrades $177 → $214 | Hold → Buy | Upgrades | $177 → $214 | +18.92% | Apr 14, 2026 |
| Citigroup | Citigroup | Hold Maintains $215 → $190 | Hold | Maintains | $215 → $190 | +5.58% | Apr 13, 2026 |
| Truist Securities | Truist Securities | Hold Maintains $193 → $189 | Hold | Maintains | $193 → $189 | +5.02% | Apr 13, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $190 → $200 | Hold | Maintains | $190 → $200 | +11.14% | Apr 10, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $228 → $237 | Strong Buy | Maintains | $228 → $237 | +31.70% | Apr 2, 2026 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $230 → $245 | Strong Buy | Maintains | $230 → $245 | +36.14% | Apr 1, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $250 → $275 | Buy | Maintains | $250 → $275 | +52.81% | Apr 1, 2026 |
| HSBC | HSBC | Sell Maintains $143 → $150 | Sell | Maintains | $143 → $150 | -16.65% | Mar 17, 2026 |
| Freedom Broker | Freedom Broker | Hold Maintains $160 → $185 | Hold | Maintains | $160 → $185 | +2.80% | Feb 23, 2026 |
| Barclays | Barclays | Hold Initiates $185 | Hold | Initiates | $185 | +2.80% | Feb 20, 2026 |
| Wedbush | Wedbush | Hold Maintains $178 → $187 | Hold | Maintains | $178 → $187 | +3.91% | Feb 10, 2026 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $220 → $230 | Strong Buy | Maintains | $220 → $230 | +27.81% | Feb 9, 2026 |
| BMO Capital | BMO Capital | Hold Maintains $165 → $196 | Hold | Maintains | $165 → $196 | +8.91% | Feb 9, 2026 |
| Piper Sandler | Piper Sandler | Hold Maintains $157 → $177 | Hold | Maintains | $157 → $177 | -1.64% | Feb 9, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.